Effect of Conjugated Linoleic Acid-enriched Butter After 24 hours of Intestinal Mucositis Induction

References

• Keefe DM and Gibson RJ: The combination of oral and small intestinal mucositis, pediatrics and biomarkers: a particularly tricky problem! Cancer Biol Ther 5, 1282–1284, 2006.
   PubMed Web of Science ®Google Scholar
• Scully C, Epstein J, and Sonis S: Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis. Head Neck 26, 77–84, 2004.
   PubMed Web of Science ®Google Scholar
• Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, et al.: The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33, 448–460, 2007.
   PubMed Web of Science ®Google Scholar
• Russi EG, Raber-Durlacher JE, and Sonis ST: Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation. Mediators Inflamm 26, 1861–1867, 2014, article ID 518261.
   Google Scholar
• Fryar EB, Das JR, Davis JH, Desoto JA, Laniyan I, et al.: Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapy. Anticancer Res 26, 1861–1867, 2006.
   PubMed Web of Science ®Google Scholar
• Maioli TU, de Melo Silva B, Dias MN, Paiva NC, Cardoso VN, et al.: Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice. J Negat Results Biomed 13, 6, 2014.
   PubMedGoogle Scholar
• Viana ML, Santos RG, Generoso SV, Arantes RM, Correia MI, et al.: Pretreatment with arginine preserves intestinal barrier integrity and reduces bacterial translocation in mice. Nutrition 26, 218–223, 2010.
   PubMed Web of Science ®Google Scholar
• Andrade MER, Araújo RS, de Barros PAV, Soares AD, Abrantes FA, et al.: The role of immunomodulators on intestinal barrier homeostasis in experimental models. Clin Nutr 34(6), 1080–1087, 2015.
   PubMed Web of Science ®Google Scholar
• Leocádio PCL, Antunesa MM, Teixeira LG, Leonel AJ, Alvarez-Leite JI, et al.: L-Arginine pretreatment reduces intestinal mucositi as induced by 5-FU in mice. Nutr Cancer 67, 486–493, 2015.
   PubMed Web of Science ®Google Scholar
• Generoso SDV, Rodrigues NM, Trindade LM, Paiva NC, Cardoso VN, et al.: Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice. Lipids Health Dis 12, 54, 2015.
   Web of Science ®Google Scholar
• Penedo LA, Nunes JC, Gama MAS, Leite PEC, Quirico-Santos TF, et al.: Intake of butter naturally enriched with cis9, trans11 conjugated linoleic acid reduces systemic inflammatory mediators in healthy young adults. J Nutr Biochem 24, 2144–2151, 2013.
   PubMed Web of Science ®Google Scholar
• Jutzeler RP, Wijlen V, and Colombani PC: Grass-based ruminant production methods and human bioconversion of vaccenic acid with estimations of maximal dietary intake of conjugated linoleic acids. Int Dairy J 20, 433–448, 2010.
   Web of Science ®Google Scholar
• Desroches S, Chouinard PY, Galibois I, Corneau L, Delisle J, et al.: Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr 82, 309–319, 2005.
   PubMed Web of Science ®Google Scholar
• Silveira MB, Carraro R, Monereo S, and Tébar J: Conjugated linoleic acid (CLA) and obesity. Public Health Nutr 10, 1181–1186, 2007.
   PubMed Web of Science ®Google Scholar
• Kennedy A, Martinez K, Schmidt S, Mandrup S, LaPoint K, et al.: Antiobesity mechanisms of action of conjugated linoleic acid. J Nutr Biochem 21, 171–179, 2010.
   PubMed Web of Science ®Google Scholar
• Almeida MM, Luquetti SC, Sabarense CM, do Amaral Corrêa JO, dos Reis LG, et al.: Butter naturally enriched in cis-9, trans-11 CLA prevents hyperinsulinemia and increases both serum HDL cholesterol and triacylglycerol levels in rats. Lipids Health Dis 13, 200, 2014.
   PubMed Web of Science ®Google Scholar
• Reynolds CM, Loscher CE, Moloney AP, and Roche HM: Cis-9, trans-11-conjugated linoleic acid but not its precursor trans-vaccenic acid attenuate inflammatory markers in the human colonic epithelial cell line Caco-2. Br J Nutr 100, 13–17, 2008.
   PubMed Web of Science ®Google Scholar
• Bassaganya-Riera J, Viladomiu M, Pedragosa M, De Simone C, and Hontecillas R: Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria. PLoS One 7, e34676, 2012.
   PubMed Web of Science ®Google Scholar
• Bassaganya-Riera J and Hontecillas R: CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin Nutr 25, 454–465, 2006.
   PubMed Web of Science ®Google Scholar
• Borniquel S, Jadert C, and Lundberg JO: Dietary conjugated linoleic acid activates PPAR g and the intestinal trefoil factor in SW480 cells and mice with dextran sulfate. J Nutr 142, 2135–2140, 2012.
   PubMed Web of Science ®Google Scholar
• Nestel P, Fujii A, and Allen T: The cis-9,trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis 189, 282–287, 2006.
   PubMed Web of Science ®Google Scholar
• Basu S, Risérus U, Turpeinen A, and Vessby B: Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci 99, 511–516, 2000.
   PubMed Web of Science ®Google Scholar
• Raff M, Tholstrup T, Basu S, Nonboe P, Sørensen MT, et al.: A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men. J Nutr 138, 509–514, 2008.
   PubMed Web of Science ®Google Scholar
• Taylor JSW, Williams SRP, Rhys R, James P, and Frenneaux MP: Conjugated linoleic acid impairs endothelial function. Arterioscler Thromb Vasc Biol 26, 307–312, 2006.
   PubMed Web of Science ®Google Scholar
• Park Y: Conjugated linoleic acid (CLA): good or bad trans fat? J Food Compos Anal 22, 4–12, 2009.
   Web of Science ®Google Scholar
• Barros PAV, Glória MBA, Lopes FCF, Gama MAS, Souza SM, et al.: Nutritional quality and oxidative stability of butter obtained from cows fed sugar-cane supplemented with sunflower oil. Arq Bras Med Vet Zootec 65, 1545–1553, 2013.
   Google Scholar
• Reeves PG, Nielsen FH, and Fahey GC: AIN-93 purified diets for laboratory rodents—final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939–1951, 1993.
   PubMed Web of Science ®Google Scholar
• Andrade MER, Santos RD, Soares AD, Costa KA, Fernandes SO, et al.: Pretreatment and treatment with L-arginine attenuate weight loss and bacterial translocation in dextran sulfate sodium colitis. J Parenter Enteral Nutr 8, 2015.
   Google Scholar
• Generoso SV, Viana ML, Santos RG, Arantes RM, Martins FS, et al.: Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. Eur J Nutr 50, 261–269, 2011.
   PubMed Web of Science ®Google Scholar
• Martins FS, Silva AA, Vieira AT, Barbosa FH, Arantes RM, et al.: Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol 191, 623–630, 2009.
   PubMed Web of Science ®Google Scholar
• Martins FS, Elian SD, Vieira AT, Tiago FC, Martins AK, et al.: Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever. Int J Med Microbiol 301, 359–364, 2011.
   PubMed Web of Science ®Google Scholar
• Martins F.S, Elian SD, Vieira AT, Tiago FC, Martins AK, et al.: Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever. Int J Med Microbiol 301, 359–364, 2011.
   PubMed Web of Science ®Google Scholar
• Shiga K, Katagiri K, Ogawa T, Kato K, Asada Y, et al.: Concomitant chemoradiotherapy using docetaxel, cisplatin and 5-FU for the patients with advanced hypopharyngeal cancer: second report. J Clin Oncol 33(15), e17074, 2015.
   Web of Science ®Google Scholar
• Ferreira TM, Leonel AJ, Melo MA, Santos RR, Cara DC, et al.: Oral supplementation of butyrate reduces mucositis and intestinal permeability associated with 5-fluorouracil administration. Lipids 47, 669–678, 2012.
   PubMed Web of Science ®Google Scholar
• Li X and Slayton WB: Molecular mechanisms of platelet and stem cell rebound after 5-fluorouracil treatment. Exp Hematol 41, 635–645, 2013.
   PubMed Web of Science ®Google Scholar
• Pritchard DM, Potten CS, and Hickman JA: The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res 58, 5453–5465, 1998.
   PubMed Web of Science ®Google Scholar
• Lee SH: Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest Res 13, 11, 2015.
   PubMed Web of Science ®Google Scholar
• Pabst O: New concepts in the generation and functions of IgA. Nat Rev Immunol 12, 821–832, 2012.
   PubMed Web of Science ®Google Scholar
• Soares PMG, Mota JM, Souza EP, Justino PF, Franco AX, et al.: Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4. Cytokine 61, 46–49, 2013.
   PubMed Web of Science ®Google Scholar
• Soares PMG, Mota JM, Gomes AS, Oliveira RB, Assreuy AM, et al.: Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 63, 91–98, 2008.
   PubMed Web of Science ®Google Scholar
• Vinolo MAR, Rodrigues HG, Nachbar RT, and Curi R: Regulation of inflammation by short chain fatty acids. Nutrients 3, 858–876, 2011.
   PubMed Web of Science ®Google Scholar
• Xavier RJ and Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427–434, 2007.
   PubMed Web of Science ®Google Scholar
• Yeung CY, Chan WT, Jiang CB, Cheng ML, Liu CY, et al.: Amelioration of chemotherapy-induced intestinal mucositis by orally administered probiotics in a mouse model. PLoS One 10, 1–16, 2015.
   Web of Science ®Google Scholar
• Sonis ST: Pathobiology of mucositis. Semin Oncol Nurs 20, 11–15, 2004.
   PubMedGoogle Scholar
• Gaullier JM, Berven G, Blankson H, and Gudmundsen O: Clinical trial results support a preference for using CLA preparations enriched with two isomers rather than four isomers in human studies. Lipids 37, 1019–1025, 2002.
   PubMed Web of Science ®Google Scholar
• Pariza MW, Park Y, and Cook ME: The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 40, 283–298, 2001.
   PubMed Web of Science ®Google Scholar
• Agueda M, Zulet MÁ, and Martínez JA: Efecto del ácido linoleico conjugado (CLA) sobre el perfil lipídico en humanos. Arch Latinoam Nutr 59, 245–252, 2009.
   PubMed Web of Science ®Google Scholar
• Martínez I, Perdicaro DJ, Brown AW, Hammons S, Carden TJ, et al.: Diet-induced alterations of host cholesterol metabolism are likely to affect the gut microbiota composition in hamsters. Appl Environ Microbiol 79, 516–524, 2013.
   PubMed Web of Science ®Google Scholar
• Souza DG, Vieira AT, Soares AC, Pinho V, Nicoli JR, et al.: The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 173, 4137–4146, 2004.
   PubMed Web of Science ®Google Scholar
• Souza DG, Fagundes CT, Amaral FA, Isalpino D, Sousa LP, et al.: The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J Immunol 179, 8533–8543, 2007.
   PubMed Web of Science ®Google Scholar
• Fagundes CT, Amaral FA, Teixeira AL, Souza DG, and Teixeira MM: Adapting to environmental stresses: the role of the microbiota in controlling innate immunity and behavioral responses. Immunol Rev 245, 250–264, 2012.
   PubMed Web of Science ®Google Scholar
• Stringer AM: Interaction between host cells and microbes in chemotherapy-induced mucositis. Nutrients 5, 1488–1499, 2013.
   PubMed Web of Science ®Google Scholar